openPR Logo
Press release

Automated Insulin Delivery Systems Market to Grow at 9.7% CAGR by 2031: Driving the Future of Diabetes Care | Major Companies are Medtronic, Novo Nordisk, Insulet Corporation.

09-23-2025 01:00 PM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Automated Insulin Delivery Systems Market

Automated Insulin Delivery Systems Market

The Automated Insulin Delivery Systems Market is expected to reach at a CAGR of 9.7% during the forecast period (2024- 2031)

The Automated Insulin Delivery Systems Market focuses on devices that automate insulin administration for diabetes management. Combining continuous glucose monitors (CGM) and insulin pumps, these systems maintain optimal glucose levels with minimal patient intervention. Market growth is driven by rising diabetes prevalence, technological advancements, and the increasing demand for convenient, precise glucose control. End-users include hospitals, diabetes clinics, and individual patients. Enhanced patient compliance, reduced complications, and integration with digital health platforms further support adoption.

πŸ“Œ Download Sample Report to Identify Emerging Deals & Opportunities in the Automated Insulin Delivery Systems Market Landscape:- https://datamintelligence.com/download-sample/automated-insulin-delivery-systems-market?rk

β˜› Automated Insulin Delivery Systems Market Recent Developments 2025:

United States: Recent Industry Developments

βœ… In February 2025, the FDA cleared Tandem Diabetes Care's Control-IQ+ interoperable automated glycemic controller for use in people aged 2+ with type 1 diabetes and adults with type 2 diabetes, expanding its previous indication beyond type 1 only.

βœ… In May 2025, Sequel Med Tech announced the U.S. launch date of its twiist Automated Insulin Delivery (AID) system for July 7, built through a partnership with Senseonics, integrating the 1-year Eversense CGM.

βœ… In August 2024, Insulet's Omnipod 5 AID system received FDA clearance for type 2 diabetes management in adults, making it the first AID system in the U.S. officially indicated for both type 1 and type 2 diabetes.

Japan: Recent Industry Developments

βœ… In 2020, Diabeloop SA and Terumo Corporation signed a joint development agreement granting Terumo exclusive rights in Japan for the DBLG1 automated insulin delivery solution integrated with its MEDISAFE WITH patch pump.

βœ… In April 2025, Kyoto University Hospital completed a clinical transplant of iPS cell-derived pancreatic islet cells under the skin in a type 1 diabetes patient, marking progress toward naturally producing insulin and potentially reducing the need for daily injections.

β˜› Automated Insulin Delivery Systems Market Trends:

The automated insulin delivery systems market is growing due to the rising prevalence of diabetes, particularly type 1 diabetes, and increasing demand for technology-driven glucose management solutions. Advances in continuous glucose monitoring and algorithm-driven insulin pumps are improving patient outcomes.

Trends include hybrid closed-loop systems for more precise insulin delivery, integration with wearable devices and mobile apps for real-time monitoring, and expansion into pediatric and geriatric patient segments to increase market penetration.

β˜› Automated Insulin Delivery Systems Market Competitve Landscape:

Medtronic, Novo Nordisk, Insulet Corporation , Tandem Diabetes Care, Inc, Ypsomed AG, F. Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Biocon, Bigfoot Biomedical, Inc. and sanofi-aventis U.S. LLC.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

πŸ“Œ Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/automated-insulin-delivery-systems-market

β˜› Segment Covered in the Automated Insulin Delivery Systems Market:

By Device Type: Reusable Insulin Pens, Disposable Insulin Pens

By Insulin Pumps: External/ Tethered Pumps, Implanted Insulin pump (IIP), Patch Pumps, Closed-loop insulin pump, Others

By Pen Needles: Standard Pen Needles, Safety Pen Needles, Others

By End-User: Hospitals, Clinics, Homecare, Others

β˜› This Report Includes:

βœ” Comprehensive go-to-market strategies with actionable insights.

βœ” Unbiased evaluation of overall market performance.

βœ” Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

βœ” Tailored regional and country-level reports with detailed localized analysis available on request.

βœ” Identification of niche segments and high-growth regions presenting strong opportunities.

βœ” Accurate regional forecasts using both top-down and bottom-up approaches.

πŸ“Œ Get Corporate Access to Live Automated Insulin Delivery Systems Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=automated-insulin-delivery-systems-market

β˜› Regional Analysis for Automated Insulin Delivery Systems Market:

β‡₯ North America (U.S., Canada, Mexico)

β‡₯ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

β‡₯ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

β‡₯ South America (Colombia, Brazil, Argentina, Rest of South America)

β‡₯ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

β˜› Frequently asked questions:

➠ What is the global sales, production, consumption, import, and export value of the Automated Insulin Delivery Systems Market?
➠ Who are the key global manufacturers, and what is their operational performance?
➠ What are the major opportunities and threats in the global Automated Insulin Delivery Systems Market?
➠ Which product types or end-users show the most growth potential and market share?
➠ What challenges and constraints are impacting the Automated Insulin Delivery Systems Market?
➠ What sales, marketing, and distribution channels are used globally?

πŸ“Œ Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

β˜› Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

βœ… Competitive Landscape
βœ… Sustainability Impact Analysis
βœ… KOL / Stakeholder Insights
βœ… Unmet Needs & Positioning, Pricing & Market Access Snapshots
βœ… Market Volatility & Emerging Risks Analysis
βœ… Quarterly Industry Report Updated
βœ… Live Market & Pricing Trends
βœ… Import-Export Data Monitoring

β˜› Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Automated Insulin Delivery Systems Market to Grow at 9.7% CAGR by 2031: Driving the Future of Diabetes Care | Major Companies are Medtronic, Novo Nordisk, Insulet Corporation. here

News-ID: 4194010 • Views: …

More Releases from DataM Intelligence 4market Research LLP

United States & Japan Lead Innovation in Robotic Prosthetics with AI, Muscle-Tissue & Neurotech Advances | Top Companies are HDT Global; Ottobock; EndoliteSynTouch, Inc
United States & Japan Lead Innovation in Robotic Prosthetics with AI, Muscle-Tis …
Robotic Prosthetic Market reached US$ 1.63 Billion in 2024 and is expected to reach US$ 3.16 Billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033. The Robotic Prosthetic Market involves advanced prosthetic limbs integrated with robotics and smart technologies for improved mobility, dexterity, and functionality. These devices leverage sensors, AI, and actuators to provide natural movement and user control. Market expansion is supported by increasing limb…
Japan Cell Banking Outsourcing Market to Grow at 15.2% CAGR (2024-2031) Driven by AI, Automation, and Advanced Cryopreservation Innovations | Charles River Laboratories, Inc, Merck KGaA
Japan Cell Banking Outsourcing Market to Grow at 15.2% CAGR (2024-2031) Driven b …
The Cell Banking Outsourcing Market is estimated to reach at a CAGR of 15.2 % during the forecast period (2024-2031) Cell banking outsourcing involves contracting external specialized facilities to create, store, and manage cell banks used in biopharmaceutical research and production. This process is essential for preserving cell lines that serve as the foundation for producing therapeutic proteins, vaccines, and other biological products. Outsourcing cell banking enables companies to maintain high-quality,…
Genomic Biomarker Market 2025 Opportunity, Challenge, Drivers, and Global Growth by 2031 | Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., Myriad Genetics, Inc., QIAGEN
Genomic Biomarker Market 2025 Opportunity, Challenge, Drivers, and Global Growth …
Genomic Biomarker Market is valued at a significant CAGR during the forecast period (2024-2031). As per DataM Intelligence Database. The Genomic Biomarker Market focuses on molecular indicators derived from DNA, RNA, or proteins, used to detect disease, predict progression, and guide targeted therapies. These biomarkers play a critical role in personalized medicine, oncology, and drug development. Market growth is fueled by rising demand for precision diagnostics, increasing investments in genomics research,…
United States Non-Hodgkin Lymphoma Market to Reach $13.5 Billion by 2031 | AbbVie, Inc. , AstraZeneca plc, Bayer AG & Bristol-Myers Squibb Company.
United States Non-Hodgkin Lymphoma Market to Reach $13.5 Billion by 2031 | AbbVi …
The Global Non-Hodgkin Lymphoma Market reached USD 7.3 billion in 2023 and is projected to witness lucrative growth by reaching up to USD 13.5 billion by 2031. The global non-Hodgkin lymphoma market is expected to exhibit a CAGR of 8.2% during the forecast period 2024-2031 The Non-Hodgkin Lymphoma (NHL) Market covers therapies, including chemotherapy, targeted drugs, and immunotherapies, for the treatment of diverse lymphatic cancers. NHL is characterized by abnormal growth…

All 5 Releases


More Releases for Insulin

Insulin Delivery System Advancement Drives the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR This…
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful…
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful…
Insulin Pumps Market Share, Trends and Growth Analysis By Type (Traditional Insu …
Insulin Pumps Market is expected to register a CAGR of 15.5% and acquire the market value of USD 11.5 Billion by 2028 during forecast period 2023-2032. Insulin pumps are discreet, electronic medical devices that can be tucked beneath clothing or fastened to a belt. In order to regulate the rise in blood glucose levels, the pump is used to deliver controlled quantities of insulin within the body at regular intervals…
Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,…
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin…